|
Increasing the health equity and population-level impact of a digital therapeutic for smokers with psychiatric illness |
1K02DA054304-01A1 |
|
NIDA |
2022 |
|
A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women |
1K23DA053433-01A1 |
|
NIDA |
2022 |
|
Role of disability and pain in opioid overdose: mechanism and risk mitigation |
1R01DA053243-01A1 |
|
NIDA |
2022 |
|
Impact of Medicare Part D opioid safety policies on disabled beneficiaries before and during the COVID-19 pandemic |
1R01DA055131-01 |
|
NIDA |
2022 |
|
Improving MOUD Access, Opioid-Related Outcomes and Equity Among Medicare Beneficiaries with Disability |
1R01DA057568-01 |
|
NIDA |
2022 |
|
Social determinants of substance use disorder treatment outcomes in a vulnerable population |
1R21DA055229-01 |
|
NIDA |
2022 |
|
A telehealth tDCS approach to decrease cannabis use: Towards reducing multiple sclerosis disability in multiple sclerosis |
1R21DA055427-01 |
|
NIDA |
2022 |
|
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools |
1R21DA056293-01 |
|
NIDA |
2022 |
|
A pilot study of ambulatory Heart Rate Variability Biofeedback for substance use disorder |
1R21DA056468-01 |
|
NIDA |
2022 |
|
Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder |
1UG3DA054746-01A1 |
|
NIDA |
2022 |